Literature DB >> 7769943

Perioperative ketorolac tromethamine and postoperative hemorrhage in cases of tonsillectomy and adenoidectomy.

J E Gallagher1, J Blauth, J A Fornadley.   

Abstract

The charts of 258 patients undergoing tonsillectomy with or without adenoidectomy between June 1991 and June 1993 were reviewed. One hundred sixty-nine of these patients received ketorolac tromethamine during the perioperative period as a nonnarcotic alternative for postoperative pain management. The incidence of postoperative hemorrhage among patients who received ketorolac tromethamine was 10.1%, compared to 2.2% in those patients who received narcotic analgesia only. The average time to adequate oral intake and discharge was evaluated. Ketorolac appeared to moderately decrease the time to adequate oral intake. The use of ketorolac did not significantly alter the time to discharge. The increased incidence of postoperative hemorrhage in patients receiving ketorolac should be considered before this medication is used in the perioperative period. The risk/benefit ratio of ketorolac use as a postoperative analgesic may be better demonstrated in a prospective study.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769943     DOI: 10.1288/00005537-199506000-00008

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Nonsteroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy.

Authors:  Sharon R Lewis; Amanda Nicholson; Mary E Cardwell; Gretchen Siviter; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2013-07-18

3.  Tonsillectomies, ketorolac, and the march of progress.

Authors:  S C Hall
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

Review 4.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 5.  Ketorolac for postoperative pain management in children.

Authors:  J B Forrest; E L Heitlinger; S Revell
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

Review 6.  Minimising the adverse effects of ketorolac.

Authors:  D I Reinhart
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 7.  Current guidelines for the treatment of acute pain in children.

Authors:  V Bhatt-Mehta
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

8.  Patterns of Ketorolac dosing by emergency physicians.

Authors:  Emil Soleyman-Zomalan; Sergey Motov; Antonios Likourezos; Victor Cohen; Illya Pushkar; Christian Fromm
Journal:  World J Emerg Med       Date:  2017

Review 9.  Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.

Authors:  Victoria C Ziesenitz; Tatjana Welzel; Madelé van Dyk; Patrick Saur; Matthias Gorenflo; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2022-09-02       Impact factor: 3.930

10.  Intramuscular ketorolac injections in the athlete.

Authors:  Gregory A Sawyer; Brett C Anderson; Neha P Raukar; Paul D Fadale
Journal:  Sports Health       Date:  2012-07       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.